Access to Medicines

Public Citizen's Access to Medicines Program works to challenge Big Pharma’s economic and political power in the U.S. and abroad. We work with partners worldwide to improve health outcomes and save lives, through use of pharmaceutical cost-lowering measures including generic competition. We support civil society groups and public agencies with analysis, technical assistance, and strategic advocacy to help overcome prescription drug corporations’ monopoly power.

Peter Maybarduk, Director of the Access to Medicines Program, Featured on CNBC:

Read about the Trump Administration's draft executive order on Drug Pricing.

Sign up here to take action!